查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855383

獸用免疫診斷市場依產品類型、技術、動物種類、通路、應用及最終用戶分類－2025-2032年全球預測

Veterinary Immunodiagnostics Market by Product Type, Technology, Animal Type, Distribution Channel, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，獸醫免疫診斷市場規模將達到 27.4 億美元，複合年成長率為 8.43%。

關鍵市場統計數據
基準年 2024 14.3億美元
預計年份：2025年 15.4億美元
預測年份 2032 27.4億美元
複合年成長率 (%) 8.43%

全面檢視技術創新、臨床需求和營運現實如何融合，從而重新定義獸醫免疫診斷學

獸醫免疫診斷正處於曲折點，科學進步與不斷變化的臨床需求正在融合，重塑動物疾病的檢測、管理和預防方式。過去十年，診斷平台已從客製化的實驗室工作流程轉型為更整合、自動化、快速反應的系統，能夠在不同的醫療環境中做出及時的臨床決策。因此，獸醫、診斷實驗室和研究機構越來越重視免疫診斷解決方案，不再僅僅將其視為試劑和儀器，而是將其視為更廣泛的醫療保健生態系統的組成部分，該生態系統還包括數據分析、照護現場能力和供應鏈管理。

在這種瞬息萬變的環境中，適應能力至關重要。相關人員必須在技術創新和營運可靠性這兩大迫切需求之間取得平衡，同時也要應對不斷變化的法律規範和採購慣例。因此，高階主管需要清楚了解主流診斷方法、產品外形規格以及最終用戶對產品應用的需求。此外，供應鏈的韌性、試劑品質以及與實驗室資訊系統的互通性也正成為採購決策的關鍵因素。所有這些因素共同促使企業採取策略性方法，在科學嚴謹性、商業性可行性和服務交付模式之間取得平衡，以確保診斷解決方案能夠滿足日益複雜的獸醫需求。

快速檢測技術創新、工作流程自動化和不斷發展的分銷模式如何共同重塑獸醫免疫診斷的未來

由於技術、臨床和商業性趨勢的融合，獸醫免疫診斷領域正經歷顯著的變化。檢測化學和檢測平台的快速發展提高了分析靈敏度和通量，從而實現了更快、更準確的疾病檢測。同時，自動化和整合儀器的興起減少了人工時間和操作差異，使得診斷服務能夠從專業實驗室擴展到分散的臨床機構。因此，產品設計越來越注重工作流程效率、可重複性和與數位化彙報系統的兼容性。

隨著技術進步，臨床需求也在不斷成長，範圍和複雜性日益增加。伴侶動物和牲畜的診療實踐需要診斷技術來支持預防保健、疫情應對和食品安全保障。這種轉變凸顯了多重檢測能力和快速週轉的重要性，使獸醫和生產者能夠提供實證介入措施。此外，監管環境和品質保證要求也不斷改進，促使製造商加強對驗證、文件記錄和上市後監測策略的投入，以證明產品的臨床效用和可靠性。

商業模式也在不斷演變。如今，分銷管道融合了傳統的線下關係和日益成長的線上採購管道，後者強調便利性和快速補貨週期。隨著企業尋求從整合的產品系列和服務中獲取更大價值，診斷公司、製藥公司和實驗室網路之間的策略夥伴關係也不斷加強。總而言之，這些變化凸顯了整合策略的必要性，該策略應將產品創新與監管合規性、臨床適用性和可擴展的分銷管道相結合。

美國2025年關稅對營運和採購的影響，以及產業參與者如何調整其採購和定價策略

2025年美國關稅政策引入了一系列重新調整的貿易考量因素，將影響獸醫免疫診斷供應鏈的採購籌資策略和成本結構。依賴跨境供應儀器、試劑和檢測組件的製造商和經銷商不得不重新評估其供應商合約、庫存政策和供應商多元化策略，以確保服務的連續性。因此，採購團隊正在加快供應商資質審核流程，並強調採用多源採購框架，以降低單點故障的風險。

此外，關稅環境加劇了人們對本地產能和區域製造夥伴關係關係的關注。相關人員正積極探索近岸外包和雙重採購方案，以減輕進口關稅的影響，同時確保獲得關鍵原料和特殊組件。此類重組通常需要前期投資於供應商開發和品質體系，以確保替代供應商符合診斷所需的驗證標準。此外，經銷商和臨床終端用戶也改進了庫存管理實踐，透過增加安全庫存和與臨床需求訊號相關的預測性補貨，為應對突發的供應中斷做好準備。

值得注意的是，主導調整也影響策略定價和合約簽訂方式。商務團隊擴大協商包含關稅減免和供應連續性條款的長期契約，而製造商則在探索附加價值服務組合，以證明價格調整的合理性。總而言之，這些因應措施反映了整個產業為在應對最新貿易措施帶來的實際影響的同時，努力維持臨床對關鍵免疫診斷工具的獲取而做出的共同努力。

解讀產品、技術、物種、分銷、應用和最終用戶細分，以幫助確定產品開發和商業化策略的優先順序。

了解市場區隔的細微差別有助於明確產品開發和商業化工作的重點方向，從而滿足多樣化的臨床和營運需求。從產品類型角度來看，市場可分為三大類：免疫檢測套件、儀器、試劑。免疫檢測套件包括化學冷光免疫檢測套件、螢光免疫分析法套件(ELISA) 試劑套件、螢光免疫橫向流動化驗免疫分析套件和放射免疫測量套件，每種試劑盒都服務於不同的應用場景，從高通量實驗室檢測到照護現場篩檢。儀器包括自動化免疫檢測系統、化學冷光系統、發光儀和微孔盤讀數儀，它們在通量、自動化程度和分析能力方面各有側重。試劑包括抗原、抗體、緩衝液和溶液，這些都是檢測性能的基礎，需要嚴格的品管。

這些技術包括化學冷光免疫檢測、流式細胞技術、螢光免疫分析、免疫組織化學、側向流動免疫檢測、放射免疫測量和西方印漬術。有些技術具有更高的靈敏度和定量能力，而有些技術則無需儀器即可快速部署，適用於現場使用。這些技術差異會影響驗證路徑、最終使用者培訓和實驗室整合等方面的決策。

動物類型的引入進一步細化了產品優先順序。水生動物、伴侶動物和家畜各自呈現不同的流行病學特徵和檢測要求。伴侶動物診斷通常優先考慮犬貓應用，重點在於個人化護理和預防性篩檢。相反，家畜診斷必須支持牛、羊、家禽和豬等畜牧業，這些畜群層面的監測、疫情的快速檢測以及食品安全問題都影響著人們對產品的期望。

通路分為線下和線上，兩者需要不同的服務模式。線下通路傳統上專注於現場銷售、技術支援和長期供貨關係，而線上採購則加快了補貨週期，並支援機構買家的標準化採購。應用領域涵蓋自體免疫疾病診斷、癌症診斷、食品安全和品質檢測、荷爾蒙和代謝紊亂診斷、感染疾病診斷、懷孕和不孕症檢測以及毒素檢測。這些應用案例驅動著檢測設計、監管要求和臨床驗證終點。最終用戶包括診斷實驗室、製藥和生物技術公司、研究機構以及獸醫醫院和診所，每個用戶都有各自的營運限制和採購標準，因此需要客製化的產品功能和服務。

綜合來看，細分市場洞察凸顯了產品系列、檢驗策略和通路方法的一致性的重要性，這反映了不同技術、動物類型和最終用途背景下的多樣化需求。

美洲、歐洲、中東和非洲以及亞太地區的市場競爭和差異化需求將影響目標市場策略和產品在地化。

區域動態帶來了不同的商業機會和營運考量，這些都應指南市場進入和擴大策略。在美洲，成熟的實驗室網路和強大的私人獸醫行業推動了對高性能檢測設備和檢驗的檢測試劑套件的需求。這種環境有利於那些能夠提供強大的技術支援、符合監管要求以及能夠同時滿足伴侶動物診療和大型畜牧業營運需求的綜合服務模式的供應商。相較之下，歐洲、中東和非洲地區（EMEA）的管理體制和基礎設施能力差異很大。市場參與企業必須滿足各種不同的合規要求，同時設計能夠適應監管嚴格市場和實驗室能力有限地區的解決方案。戰略夥伴關係和區域分銷協議通常在企業在這個多元化地區獲得市場認可方面發揮著至關重要的作用。

亞太地區的情況十分複雜，既有快速部署，也有基礎設施差異。該地區多個國家正在擴大獸醫服務和食品安全計劃，從而在寵物食品和畜牧業領域催生了對可擴展診斷技術的需求。同時，當地的生產能力和成本敏感度影響採購決策，迫使跨國公司考慮建立生產夥伴關係、授權合約，並開發符合當地性價比預期的產品版本。動物生產系統的變化、水產養殖的集約化以及對飼料和食品安全監管力度的加大，都將進一步影響該地區的產品優先順序。在所有地區，物流、監管協調工作以及本地技術支援能力仍然是決定成功部署和持續應用的關鍵因素。

競爭動態產品組合深度、創新速度、策略聯盟和附加價值服務模式，這些因素決定了市場定位和成長路徑。

獸醫免疫診斷領域的競爭格局融合了成熟跨國診斷公司的優勢、專業創新企業的敏捷性以及獸醫服務供應商的專業化優勢。大型公司通常憑藉全面的、經過驗證的檢測試劑套件、可靠的試劑和儀器產品組合脫穎而出，並投資於品質保證和法規遵從性，以支持臨床應用。同時，規模較小、更靈活的公司往往專注於即時檢測、新型化合物或獨特的物種特異性診斷，並且在檢驗創新方法和滿足特定應用需求方面更加敏捷。

共同研究模式正變得越來越普遍。儀器製造商和試劑供應商之間的商業性夥伴關係打造了捆綁式解決方案，從而減少了實驗室和臨床採購人員的整合障礙。同樣，與當地經銷商和服務供應商的聯盟可以將技術支援能力擴展到基礎設施各異的地區。競爭優勢還取決於售後服務、培訓以及能夠簡化結果解讀和報告的數位化工具。在技​​術能力參差不齊的市場中，這些附加價值服務往往決定產品的普及程度。最後，在伴侶動物和牲畜市場，易用性和分析性能的可靠性是購買決策的核心，因此，那些設計出符合最終用戶工作流程和監管要求的產品的公司將確保更高的市場接受度。

為加強供應鏈、改善驗證途徑、擴大商業性覆蓋範圍並加速技術在不同獸醫領域的應用，提出切實可行的策略建議。

在瞬息萬變的環境中，產業領導者應採取一系列切實可行的措施來創造價值並降低營運風險。首先，應優先投資於兼顧分析性能和工作流程效率的檢測平台和儀器，確保產品能夠滿足集中式實驗室和分散式臨床環境的需求。為此，將驗證策略與監管要求和最終用戶用例相結合，可加速臨床應用並整合到診療流程中。其次，應透過供應商多元化、區域製造夥伴關係以及完善的品質系統來增強供應鏈韌性，從而降低貿易中斷帶來的風險，並維持試劑的穩定供應。

第三，我們將拓展商業模式，融合線下技術支援與線上採購的便利性，同時滿足機構買家和小型臨床診所的需求。為改善分銷管道，我們將與實驗室網路、動物保健服務機構和研究組織建立策略夥伴關係，共同開發應用產品，並在實際環境中檢驗其臨床效用。第四，我們將投資於數位化工具和數據分析，以增強檢測結果的解讀、促進監控並實現預測性補貨。這些數位化能力不僅能夠改善臨床決策，還能創造持續的價值流，進而加強顧客關係。

最後，我們將採取區域適應性策略，在遵循全球標準的同時兼顧本地化需求，包括根據各地區的法律規範、成本敏感性和基礎設施實際情況調整產品。透過協調一致地實施這些措施，產業相關人員可以增強市場韌性，加速先進診斷技術的應用，並更好地支持不同物種和地區的動物健康。

透過透明的多方法調查方法，結合專家的一手研究、實驗室檢驗和系統的二手分析，獲得可靠的洞見。

本分析採用透明的多方法調查方法綜合證據，旨在確保研究結果的相關性和嚴謹性。主要研究包括對實驗室主任、獸醫臨床醫生、採購專業人員和行業高管進行結構化訪談，以了解實踐現狀、驗證預期和採購促進因素。這些質性訪談有助於我們解讀技術採納模式以及影響最終使用者選擇的實際限制因素。次要研究包括對科學文獻、監管指南和產品文件進行系統性回顧，以檢驗檢測特性並了解每項技術的優點和限制。

在條件允許的情況下，我們審查了實驗室層面的檢驗研究和技術性能數據，以支持關於靈敏度、特異性和工作流程整合的論點。我們的供應鏈評估利用了公開的貿易數據和行業披露資訊，以識別關鍵的採購依賴關係和物流限制。在整個過程中，我們整合了來自多個資訊來源的資訊，以減少偏差，並確保我們的結論既反映科學證據，也反映市場實際情況。調查方法的透明度和資訊來源的可追溯性是我們分析的基礎，使相關人員能夠評估我們的見解在其自身組織環境中的適用性。

對獸醫免疫診斷領域未來成功與否，綜合診斷創新、營運韌性和商業性可行性如何決定此問題的總結

總體而言，獸醫免疫診斷需要將技術創新與務實的營運策略結合的綜合應對方案。診斷試劑研發人員不僅要取得卓越的分析結果，還要設計出符合實驗室和臨床工作流程、滿足物種特異性需求並符合當地監管要求的產品。營運韌性，包括供應商多元化和本地化生產方式，對於維持檢測的連續性以及在疫情爆發時提供快速回應至關重要。商業性成功取決於能否透過可靠的供應、有效的售後服務以及增強臨床效用的數位化工具來提供捆綁式價值。

未來，那些將產品開發與實際應用案例相結合、投資於完善的驗證和品質系統並採用適應性分銷模式的相關人員，將更有能力支持伴侶動物、生產動物和水產養殖等各個領域的動物健康。透過整合市場的技術、監管和商業性因素，企業可以製定既能產生臨床影響又能帶來永續商業性回報的策略。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大照護現場免疫診斷設備在畜牧場快速疾病檢測的應用
  • 整合多重免疫測量，實現多種動物病原體的同時檢測
  • 開發針對新出現的通用感染疾病的免疫診斷檢測方法，以加強監測
  • 融合人工智慧演算法的數位免疫診斷平台的興起，提高了診斷準確性。
  • 側向流動免疫檢測試紙在現場檢測動物健康生物標記中的應用
  • 伴侶動物慢性疾病早期檢測免疫診斷生物標記的進展
  • 高通量自動化免疫檢測系統在商業動物診斷實驗室中的出現
  • 擴大畜牧生產中抗菌素抗藥性監測的免疫診斷檢測解決方案

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：依產品類型分類的動物免疫診斷市場

  • 免疫檢測套件
    • 化學冷光免疫檢測套件
    • ELISA（酵素結合免疫吸附試驗）套件
    • 螢光免疫分析法套件
    • 橫向流動化驗套件
    • 免疫測量（RIA）套件
  • 裝置
    • 自動化免疫檢測系統
    • 化學冷光系統
    • 發光計
    • 微孔盤讀數儀
  • 試劑
    • 抗原/抗體
    • 緩衝液和溶液

第9章：依技術分類的動物免疫診斷市場

  • 化學冷光免疫檢測
  • ELISA法
  • 流式細胞技術
  • 螢光免疫分析
  • 免疫組織化學（IHC）
  • 側向流動免疫檢測
  • 免疫測量（RIA）
  • 西方印漬術

第10章 依動物類型分類的動物免疫診斷市場

  • 水生動物
  • 伴侶動物
    • 狗
    • 貓
  • 家畜
    • 牛
    • 山羊
    • 家禽
    • 豬

第11章：按分銷管道分類的動物免疫診斷市場

  • 離線
  • 線上

第12章 動物免疫診斷市場依應用領域分類

  • 自體免疫疾病診斷試劑
  • 癌症診斷劑
  • 食品安全與品質檢驗
  • 荷爾蒙和代謝失調診斷劑
  • 感染疾病診斷
  • 妊娠和不孕症檢查
  • 毒素檢測

第13章：依最終用戶分類的動物免疫診斷市場

  • 診斷實驗室
  • 製藥和生物技術公司
  • 研究所
  • 獸醫醫院和診所

第14章：按地區分類的動物免疫診斷市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：按組別分類的動物免疫診斷市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國動物免疫診斷市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Agrolabo SpA
    • Bio-Rad Laboratories, Inc.
    • BioChek BV
    • Biogal Galed Labs
    • bioMerieux SA
    • Bionote USA Inc.
    • Biopanda Reagents Ltd.
    • EIKEN CHEMICAL CO.,LTD
    • Elanco Animal Health
    • FUJIFILM Holdings Corporation
    • GD Animal Health
    • Heska Corporation
    • IDEXX Laboratories, Inc.
    • INDICAL BIOSCIENCE GmbH
    • Innovative Diagnostics SAS
    • LABOKLIN GMBH & CO. KG
    • Neogen Corporation
    • QIAGEN NV
    • Randox Laboratories Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Thermo Fisher Scientific Inc.
    • URIT Medical Electronic Co., Ltd.
    • Virbac Animal Health India Pvt. Ltd
    • VolitionRx Limited
    • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market is projected to grow by USD 2.74 billion at a CAGR of 8.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.43 billion
Estimated Year [2025] USD 1.54 billion
Forecast Year [2032] USD 2.74 billion
CAGR (%) 8.43%

A comprehensive orientation to how technological innovation, clinical demand, and operational realities are converging to redefine veterinary immunodiagnostics

Veterinary immunodiagnostics stands at an inflection point where scientific advances and evolving clinical needs converge to reshape how diseases in animals are detected, managed, and prevented. Over the past decade, diagnostic platforms have moved from bespoke laboratory workflows toward more integrated, automated, and rapid-response systems that enable timely clinical decision-making across diverse care settings. As a result, veterinary practitioners, diagnostic laboratories, and research organizations increasingly consider immunodiagnostic solutions not merely as reagents and instruments but as components of broader health management ecosystems that include data analytics, point-of-care capabilities, and supply chain considerations.

This dynamic environment places a premium on adaptability. Stakeholders must reconcile the dual imperatives of technological innovation and operational reliability while navigating shifting regulatory frameworks and procurement practices. Therefore, executives need a clear line of sight into the prevailing diagnostic modalities, product form factors, and the end-user requirements that govern adoption. In addition, supply chain resilience, reagent quality, and interoperability with laboratory information systems have become decisive factors in purchasing decisions. Taken together, these forces necessitate a strategic approach that balances scientific rigor, commercial feasibility, and service delivery models to ensure diagnostic solutions meet the growing complexity of veterinary care.

How rapid assay innovation, workflow automation, and evolving distribution models are jointly reshaping the future of veterinary immunodiagnostics

The landscape of veterinary immunodiagnostics is undergoing transformative shifts driven by converging technological, clinical, and commercial trends. Rapid advances in assay chemistries and detection platforms have improved analytical sensitivity and throughput, enabling earlier and more accurate disease detection. At the same time, the rise of automation and integrated instrumentation has reduced hands-on time and variability, which in turn supports scaling diagnostic services from specialized labs to decentralized clinical settings. Consequently, product design is increasingly guided by the need for workflow efficiency, reproducibility, and compatibility with digital reporting systems.

Parallel to technological gains, clinical demand is expanding in scope and complexity. Practitioners across companion and livestock animal care settings require diagnostics that support preventive health, outbreak response, and food safety assurance. This shift places a premium on multiplexing capability and rapid turnaround, which allow veterinarians and producers to make evidence-based interventions. Moreover, regulatory landscapes and quality assurance expectations are maturing, prompting manufacturers to invest in validation, documentation, and post-market surveillance strategies that demonstrate clinical utility and reliability.

Commercial models are also evolving. Distribution channels now blend traditional offline relationships with growing online procurement pathways that emphasize convenience and quicker replenishment cycles. Strategic partnerships between diagnostics firms, pharmaceutical companies, and laboratory networks are intensifying, as firms seek to combine product portfolios with service delivery to capture greater value. Taken together, these transformative shifts underscore the need for integrated strategies that align product innovation with regulatory compliance, clinical applicability, and scalable distribution.

Operational and procurement consequences of United States tariff measures in 2025 and how industry participants are adapting sourcing and pricing strategies

United States tariff policies implemented in 2025 have introduced a recalibrated set of trade considerations that affect procurement, sourcing strategies, and cost structures within the veterinary immunodiagnostics supply chain. Manufacturers and distributors that rely on cross-border supply of instruments, reagents, and assay components have had to reassess vendor contracts, inventory policies, and supplier diversification to preserve continuity of service. As a result, procurement teams have accelerated supplier qualification processes and increased emphasis on multi-source frameworks to mitigate the risk of single points of failure.

In addition, the tariff environment has sharpened attention toward localized production capabilities and regional manufacturing partnerships. Stakeholders have responded by exploring nearshoring and dual-sourcing tactics that reduce exposure to import levies while preserving access to critical raw materials and specialized components. This operational realignment often requires upfront investments in supplier development and quality systems to ensure that alternative sources meet the validation standards required for diagnostic use. Furthermore, distributors and clinical end users have refined inventory management practices to buffer against episodic supply interruptions, with greater reliance on safety stock and predictive replenishment linked to clinical demand signals.

Importantly, the tariff-driven adjustments have also influenced strategic pricing and contracting approaches. Commercial teams are increasingly negotiating longer-term agreements that include clauses for duty mitigation and supply continuity, and manufacturers are exploring value-added service bundles to justify any price adjustments. Collectively, these responses reflect an industry-wide effort to maintain clinical access to essential immunodiagnostic tools while navigating the practical implications of updated trade measures.

Decoding product, technology, species, distribution, application, and end-user segmentation to inform prioritized product development and commercialization strategies

A nuanced understanding of segmentation reveals where product development and commercial efforts should concentrate to meet diverse clinical and operational needs. When the market is viewed through the lens of product type, three primary categories emerge: Immunoassay Kits, Instruments, and Reagents. Immunoassay Kits span chemiluminescent immunoassay kits, ELISA kits, fluorescence immunoassay kits, lateral flow assay kits, and radioimmunoassay kits, each addressing distinct use cases ranging from high-throughput laboratory testing to rapid point-of-care screening. Instruments include automated immunoassay systems, chemiluminescence systems, luminometers, and microplate readers, offering different balances of throughput, automation, and analytical capability. Reagents cover antigens and antibodies as well as buffers and solutions, which are foundational to assay performance and require consistent quality control.

Looking at technology, the market encompasses chemiluminescence immunoassays, ELISA, flow cytometry, fluorescence immunoassays, immunohistochemistry, lateral flow immunoassays, radioimmunoassay, and Western blotting. Each technology presents distinct strengths: some excel in sensitivity and quantitative output, while others offer rapid, equipment-free deployment suitable for field use. These technological distinctions drive decisions around validation pathways, end-user training, and laboratory integration.

Animal type introductions further refine product priorities. Aquatic animals, companion animals, and livestock animals exhibit different epidemiological profiles and testing requirements. Companion animal diagnostics often prioritize canine and feline applications with a focus on individualized care and preventive screening. Conversely, livestock diagnostics must support cattle, goats, poultry, and swine sectors where herd-level surveillance, rapid outbreak detection, and food safety implications shape product expectations.

Distribution channels bifurcate into offline and online pathways, and each route demands distinct service models. Offline channels traditionally emphasize field sales, technical support, and long-term supply relationships, whereas online procurement accelerates reorder cycles and supports standardized purchasing for institutional buyers. Applications span autoimmune disease diagnostics, cancer diagnostics, food safety and quality testing, hormonal and metabolic disorder diagnostics, infectious disease diagnostics, pregnancy and fertility testing, and toxin detection. These use cases dictate assay design, regulatory requirements, and clinical validation endpoints. Finally, end users include diagnostic laboratories, pharmaceutical and biotechnology companies, research institutes, and veterinary clinics and hospitals, each bringing unique operational constraints and procurement criteria that must be addressed through tailored product features and service offerings.

Taken together, segmentation insights highlight the importance of aligned product portfolios, validation strategies, and channel approaches that reflect the varied demands across technologies, animal types, and end-use contexts.

Regional competitiveness and differentiated demand across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape targeted market strategies and product localization

Regional dynamics present differentiated opportunities and operational considerations that should guide market entry and expansion strategies. In the Americas, well-established laboratory networks and a strong private veterinary sector drive demand for high-performance laboratory instruments and validated assay kits. This environment favors suppliers that offer robust technical support, regulatory alignment, and integrated service models that address both companion animal practices and large-scale livestock operations. In contrast, Europe, Middle East & Africa encompasses a wide spectrum of regulatory regimes and infrastructure capabilities. Here, market participants must navigate varied compliance requirements while designing solutions that are adaptable to both highly regulated markets and regions where laboratory capacity may be more limited. Strategic partnerships and regional distribution agreements often play a decisive role in achieving traction across this diverse geography.

Asia-Pacific presents a complex mix of rapid adoption and infrastructure heterogeneity. Several countries in the region have expanded veterinary services and food safety programs, creating demand for scalable diagnostics across both companion and livestock sectors. At the same time, local manufacturing capabilities and cost sensitivities influence procurement decisions, prompting multinational firms to consider manufacturing partnerships, licensing arrangements, and tailored product versions that meet regional price-performance expectations. Shifts in animal production systems, intensification of aquaculture, and heightened regulatory focus on feed and food safety further influence product priorities in this region. Across all geographies, logistics, regulatory harmonization efforts, and local technical support capabilities remain pivotal factors in determining successful deployment and sustained adoption.

Competitive landscape dynamics driven by portfolio depth, innovation velocity, strategic alliances, and value-added service models that determine market positioning and growth pathways

Competitive dynamics in veterinary immunodiagnostics combine the strengths of established multinational diagnostics firms with the agility of specialized innovators and the domain expertise of veterinary service providers. Leading organizations typically differentiate through comprehensive portfolios that pair instruments with validated assay kits and reliable reagent supplies, and they invest in quality assurance and regulatory compliance to support clinical adoption. In parallel, smaller, nimble companies specialize in point-of-care assays, novel chemistries, or unique species-specific diagnostics, often moving more quickly to validate innovative modalities and to serve niche applications.

Collaboration models are increasingly common. Commercial partnerships between instrument manufacturers and reagent suppliers create bundled solutions that reduce integration friction for laboratory and clinical buyers. Likewise, alliances with local distributors or service providers extend technical support capabilities into regions with diverse infrastructure. Competitive positioning also hinges on post-sale service, training, and digital tools that streamline result interpretation and reporting. These value-added services frequently determine adoption in markets where technical capacity varies. Lastly, firms that align product design with end-user workflows and regulatory requirements secure stronger uptake, as ease of use and confidence in analytical performance are central to purchasing decisions across both companion and production animal markets.

Practical strategic recommendations to fortify supply chains, align validation pathways, and expand commercial reach while accelerating technology adoption across diverse veterinary settings

Industry leaders should pursue a set of pragmatic actions to capture value and mitigate operational risk in a rapidly changing environment. First, prioritize investment in assay platforms and instrumentation that balance analytical performance with workflow efficiency, ensuring that products meet the needs of both centralized laboratories and decentralized clinical settings. To that end, aligning validation strategies with regulatory expectations and end-user use cases will accelerate clinical acceptance and integration into care pathways. Second, reinforce supply chain resilience through supplier diversification, regional manufacturing partnerships, and robust quality systems to reduce exposure to trade-related disruptions and to maintain steady reagent availability.

Third, expand commercial models to blend offline technical engagement with online procurement conveniences, thereby catering to institutional buyers and smaller clinical practices simultaneously. Complementary to distribution adaptations, cultivate strategic partnerships with laboratory networks, animal health services, and research organizations to co-develop applications and to validate clinical utility in real-world settings. Fourth, invest in digital tools and data analytics that enhance assay interpretation, facilitate surveillance, and enable predictive replenishment. Such digital capabilities not only improve clinical decision-making but also create recurring value streams that strengthen customer relationships.

Finally, adopt a regionally adaptive strategy that balances global standards with local customization. This includes tailoring product offerings to meet regional regulatory frameworks, cost sensitivities, and infrastructure realities. By implementing these actions in a coordinated manner, industry players can strengthen market resilience, accelerate adoption of advanced diagnostics, and better support animal health outcomes across species and geographies.

Transparent, multi-method research approach combining primary expert engagement, laboratory validation review, and systematic secondary analysis to ensure robust insights

This analysis synthesizes evidence through a transparent, multi-method research approach designed to ensure relevance and rigor. Primary research included structured interviews with laboratory directors, veterinary clinicians, procurement professionals, and industry executives to capture operational realities, validation expectations, and procurement drivers. These qualitative engagements informed the interpretation of technology adoption patterns and the practical constraints that shape end-user choices. Secondary research involved a systematic review of scientific literature, regulatory guidance, and product documentation to validate assay characteristics and to understand methodological strengths and limitations across technologies.

Where feasible, laboratory-level validation studies and technical performance data were reviewed to corroborate claims regarding sensitivity, specificity, and workflow integration. Supply chain assessments drew upon publicly available trade data and industry disclosures to identify key sourcing dependencies and logistical constraints. Throughout the process, findings were triangulated across multiple sources to mitigate bias and to ensure that conclusions reflect both scientific evidence and market realities. Methodological transparency and source traceability undergird the analysis, enabling stakeholders to evaluate the applicability of insights to their specific organizational contexts.

Concluding synthesis of how integrated diagnostic innovation, operational resilience, and commercial execution together determine future success in veterinary immunodiagnostics

In synthesis, veterinary immunodiagnostics requires an integrated response that couples technological innovation with practical operational strategies. Diagnostic developers must design products that not only achieve analytical excellence but also fit into the workflows of laboratories and clinics, accommodate species-specific needs, and meet regional regulatory expectations. Operational resilience, including supplier diversification and targeted regional manufacturing approaches, is essential to preserve continuity of testing and to support rapid response in outbreak scenarios. Commercial success will hinge on the ability to offer bundled value through reliable supply, meaningful post-sale service, and digital tools that enhance clinical utility.

Looking forward, stakeholders that align product development with real-world use cases, invest in robust validation and quality systems, and adopt adaptive distribution models will be best positioned to support animal health outcomes across companion, production, and aquatic sectors. By synthesizing the technological, regulatory, and commercial dimensions of the market, organizations can craft strategies that deliver both clinical impact and sustainable commercial returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of point-of-care immunodiagnostic devices for rapid on-farm disease testing in livestock
  • 5.2. Integration of multiplex immunoassays enabling simultaneous detection of multiple veterinary pathogens
  • 5.3. Development of immunodiagnostic assays targeting emerging zoonotic viruses for enhanced surveillance
  • 5.4. Rise of digital immunodiagnostic platforms incorporating AI algorithms for improved diagnostic accuracy
  • 5.5. Implementation of lateral flow immunoassay test strips for field-based detection of animal health biomarkers
  • 5.6. Advancement of immunodiagnostic biomarkers for early detection of chronic diseases in companion animals
  • 5.7. Emergence of high-throughput automated immunoassay systems in commercial veterinary diagnostic laboratories
  • 5.8. Expansion of immunodiagnostic testing solutions for antimicrobial resistance monitoring in livestock production

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Immunodiagnostics Market, by Product Type

  • 8.1. Immunoassay Kits
    • 8.1.1. Chemiluminescent Immunoassay Kits
    • 8.1.2. ELISA (Enzyme-Linked Immunosorbent Assay) Kits
    • 8.1.3. Fluorescence Immunoassay Kits
    • 8.1.4. Lateral Flow Assay Kits
    • 8.1.5. Radioimmunoassay (RIA) Kits
  • 8.2. Instruments
    • 8.2.1. Automated Immunoassay Systems
    • 8.2.2. Chemiluminescence Systems
    • 8.2.3. Luminometers
    • 8.2.4. Microplate Readers
  • 8.3. Reagents
    • 8.3.1. Antigens & Antibodies
    • 8.3.2. Buffers & Solutions

9. Veterinary Immunodiagnostics Market, by Technology

  • 9.1. Chemiluminescence Immunoassays
  • 9.2. ELISA
  • 9.3. Flow Cytometry
  • 9.4. Fluorescence Immunoassays
  • 9.5. Immunohistochemistry (IHC)
  • 9.6. Lateral Flow Immunoassays
  • 9.7. Radioimmunoassay (RIA)
  • 9.8. Western Blotting

10. Veterinary Immunodiagnostics Market, by Animal Type

  • 10.1. Aquatic Animals
  • 10.2. Companion Animals
    • 10.2.1. Canine
    • 10.2.2. Feline
  • 10.3. Livestock Animals
    • 10.3.1. Cattle
    • 10.3.2. Goats
    • 10.3.3. Poultry
    • 10.3.4. Swine

11. Veterinary Immunodiagnostics Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Veterinary Immunodiagnostics Market, by Application

  • 12.1. Autoimmune Disease Diagnostics
  • 12.2. Cancer Diagnostics
  • 12.3. Food Safety & Quality Testing
  • 12.4. Hormonal & Metabolic Disorder Diagnostics
  • 12.5. Infectious Disease Diagnostics
  • 12.6. Pregnancy & Fertility Testing
  • 12.7. Toxin Detection

13. Veterinary Immunodiagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Pharmaceutical & Biotechnology Companies
  • 13.3. Research Institutes
  • 13.4. Veterinary Clinics & Hospitals

14. Veterinary Immunodiagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Immunodiagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Immunodiagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Agrolabo S.p.A.
    • 17.3.2. Bio-Rad Laboratories, Inc.
    • 17.3.3. BioChek BV
    • 17.3.4. Biogal Galed Labs
    • 17.3.5. bioMerieux SA
    • 17.3.6. Bionote USA Inc.
    • 17.3.7. Biopanda Reagents Ltd.
    • 17.3.8. EIKEN CHEMICAL CO.,LTD
    • 17.3.9. Elanco Animal Health
    • 17.3.10. FUJIFILM Holdings Corporation
    • 17.3.11. GD Animal Health
    • 17.3.12. Heska Corporation
    • 17.3.13. IDEXX Laboratories, Inc.
    • 17.3.14. INDICAL BIOSCIENCE GmbH
    • 17.3.15. Innovative Diagnostics SAS
    • 17.3.16. LABOKLIN GMBH & CO. KG
    • 17.3.17. Neogen Corporation
    • 17.3.18. QIAGEN N.V.
    • 17.3.19. Randox Laboratories Ltd.
    • 17.3.20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 17.3.21. Thermo Fisher Scientific Inc.
    • 17.3.22. URIT Medical Electronic Co., Ltd.
    • 17.3.23. Virbac Animal Health India Pvt. Ltd
    • 17.3.24. VolitionRx Limited
    • 17.3.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY IMMUNODIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL VETERINA